EUQ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eurazeo SE

Watchlist Manager

Watchlist

Price: 48.24 EUR 0.04% Market Closed

Market Cap: €3.5B

	Eurazeo SE F:EUQ	FR
S	Sigma Healthcare Ltd OTC:SIGGF	AU
	Orkla ASA OTC:ORKLY	NO
	Goldman Sachs BDC Inc NYSE:GSBD	US
S	SAB Biotherapeutics Inc NASDAQ:SABS	US

Profitability Summary

Eurazeo SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

75%

Gross Margin is Increasing

67% > 76%

Healthy Operating Margin

23%

Sustainable 3Y Average Operating Margin

16%

Declining Operating Margin

72% > 23%

Negative Net Margin

-23%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

99% > -23%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.